Compare
GE HealthCare Technologies vs Edwards Lifesciences
MonkScore ranges and fundamentals, side by side
Key facts
GE HealthCare Technologies and Edwards Lifesciences: key facts
- In fiscal 2025, GE HealthCare Technologies Inc. reported revenue of $20.6B and net income of $2.1B.
- In fiscal 2025, Edwards Lifesciences Corporation reported revenue of $6.1B and net income of $1.1B.
- GE HealthCare Technologies Inc.'s revenue grew 4.1% a year from fiscal 2021 to fiscal 2025.
- Edwards Lifesciences Corporation's revenue grew 3.8% a year from fiscal 2021 to fiscal 2025.
- GE HealthCare Technologies Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
- Edwards Lifesciences Corporation's free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
- In the twelve months to 30 September 2026, GE HealthCare Technologies Inc. reported revenue of $20.6B and net income of $1.8B.
- In the twelve months to 30 June 2026, Edwards Lifesciences Corporation reported revenue of $6.5B and net income of $1.0B.
Side by side
GE HealthCare Technologies and Edwards Lifesciences, side by side
Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.
| Figure | GE HealthCare Technologies Inc.NASDAQ:GEHC | Edwards Lifesciences CorporationNYSE:EW |
|---|---|---|
| MonkScore | ||
| MonkScore range | 50–60as of October 2026 | 50–60as of October 2026 |
| Sector rank | 307 of 628 in Healthcare | 297 of 628 in Healthcare |
| How this score is madeDisclaimer | ||
| Profile | ||
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Devices |
| Latest fiscal year | ||
| Revenue | $20.6BFY 2025 | $6.1BFY 2025 |
| Net income | $2.1BFY 2025 | $1.1BFY 2025 |
| Free cash flow | $1.5BFY 2025 | $1.3BFY 2025 |
| Operating cash flow | $2.0BFY 2025 | $1.6BFY 2025 |
| Total debt | $10.0BFY 2025 | $705.4MFY 2025 |
| Cash | $4.5BFY 2025 | $2.9BFY 2025 |
| Last 12 months | ||
| Revenue | $20.6Bto 30 September 2026 | $6.5Bto 30 June 2026 |
| Net income | $1.8Bto 30 September 2026 | $1.0Bto 30 June 2026 |
| Free cash flow | $1.2Bto 30 September 2026 | $1.4Bto 30 June 2026 |
| Operating cash flow | $1.7Bto 30 September 2026 | $1.7Bto 30 June 2026 |
| Total debt | $10.4Bto 30 September 2026 | $704.4Mto 30 June 2026 |
| Cash | $2.9Bto 30 September 2026 | $2.9Bto 30 June 2026 |
Company pages
Each company on its own
MonkStreet provides research, not investment advice.